Clinical trialNCT06908928RecruitingPhase 1Interventional

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

SponsorMabwell (Shanghai) Bioscience Co., Ltd.Enrollment52Triple Negative Breast Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this clinical trial is to investigate if treatment with bulumtatug fuvedotin is effective in triple-negative breast cancer patients who have previously received treatment with an antibody-drug conjugates.

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope
Duarte, California, United States
Hope Rugo
Recruiting
Ucsd Moores Cancer Center
La Jolla, California, United States
Rebecca Shatsky
Recruiting
Anschutz Medical Center
Aurora, Colorado, United States
Recruiting
Uchicago Medicine Comprehensive Cancer Center
Chicago, Illinois, United States
Rita Nanda →
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Nour Abuhadra
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Bulumtatug fuvedotin

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 11 Aug 2025
Primary completion: 31 May 2027
Completion: 31 May 2028
Last update posted: 17 Mar 2026
Registered enrollment: 52
Registry id: NCT06908928

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.